Amphetamine Extended-Release Oral Suspension for Attention-Deficit/Hyperactivity Disorder.

Authors

Ann C. Childress, Touro University NevadaFollow
Heather Chow, Touro University Nevada

Document Type

Article

Publication Date

10-1-2019

Recommended Citation

Childress, A. C., & Chow, H. (2019). Amphetamine extended-release oral suspension for attention-deficit/hyperactivity disorder. Expert Review of Clinical Pharmacology, 12(10), 965-971.

Publisher's Statement

The original material can be found here: https://doi.org/10.1080/17512433.2019.1659723